Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1K Buy
212
+6
+3% +$410 ﹤0.01% 1694
2025
Q4
$12.2K Buy
206
+52
+34% +$2.82K ﹤0.01% 1738
2025
Q3
$8.5K Buy
154
+47
+44% +$2.44K ﹤0.01% 1741
2025
Q2
$4.61K Sell
107
-82
-43% -$3.16K ﹤0.01% 1849
2025
Q1
$7.48K Buy
189
+55
+41% +$2.43K ﹤0.01% 1643
2024
Q4
$5.46K Buy
134
+59
+79% +$2.46K ﹤0.01% 1681
2024
Q3
$2.92K Buy
75
+21
+39% +$836 ﹤0.01% 1883
2024
Q2
$2.36K Buy
54
+40
+286% +$1.93K ﹤0.01% 1713
2024
Q1
$668 Buy
+14
New +$629 ﹤0.01% 1907
2022
Q2
Sell
-3
Closed 1990
2022
Q1
$0 Sell
3
-13
-81% -$870 ﹤0.01% 2042
2021
Q4
$1K Buy
+16
New +$1.22K ﹤0.01% 1933

Other funds holding NGVT

UMB Bank's NGVT Position: Q1 2026 in Review

UMB Bank increased its Ingevity (NGVT) stake by 2.9% in Q1 2026, buying an estimated $410 and bringing the position to 212 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

UMB Bank first reported a position in NGVT in Q4 2021 and has held it in 11 quarters since. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • UMB Bank held 212 shares of Ingevity worth $15.1K as of Q1 2026.
  • UMB Bank bought 6 Ingevity shares in Q1 2026, an estimated $410.
  • Ingevity made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1694 holding.
  • UMB Bank first reported a position in Ingevity in Q4 2021 and has held it in 11 quarters since.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.